Sponsors / LBRX
LBRX

LB Pharmaceuticals Inc.

Company identity checked against sources

Browse linked trials and recorded changes, or follow this company for updates.

Follow company
4Trials in this database
2Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

Completion dates · Pro

Which trial dates moved later?

Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features

Included trials

Check company identity source
TrialSponsorPhaseStatusPrimary completion
Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute SchizophreniaNCT06179108LBRXPhase 2Completed2024-12-04Actual
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute SchizophreniaNCT07363577LBRXPhase 3Recruiting2027-06Estimated
52-week Open Label Safety-Tolerability StudyNCT07369154LBRXPhase 3Recruiting2028-12Estimated
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.NCT07494305LBRXPhase 2Recruiting2028-02Estimated

Latest recorded trial changes